• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[按病理类型对原发部位不明癌症的治疗管理]

[Therapeutic management of cancer of unknown primary site by pathological types].

作者信息

Fernández Cotarelo M J, Guerra Vales J M

机构信息

Servicio de Medicina Interna, Hospital de Móstoles, Móstoles, Madrid, Spain.

出版信息

Rev Clin Esp. 2009 Oct;209(9):439-43. doi: 10.1016/s0014-2565(09)72517-2.

DOI:10.1016/s0014-2565(09)72517-2
PMID:19852914
Abstract

The term cancer of unknown primary site includes metastatic tumours with different histology and behaviour. Although most of them have a poor short-term prognosis, some patients can benefit from a treatment and will achieve a longer survival. The treatable cases are: metastases of squamous carcinoma in cervical or inguinal adenopathies, metastases of adenocarcinoma in axilar adenopathies in women, malignant ascites due to adenocarcinoma in women, osteoblastic bone metastases in men with elevated serum prostatic specific antigen levels, poorly differentiated tumours with features of a germinal extragonadal tumour, poorly differentiated neuroendocrine carcinomas and patients with a single metastasis. Chemotherapy must be considered in the rest of patients, although the optimum regimen is not well established yet.

摘要

原发部位不明的癌症这一术语包括具有不同组织学和行为的转移性肿瘤。尽管其中大多数患者短期预后较差,但一些患者可从治疗中获益并获得更长的生存期。可治疗的病例包括:宫颈或腹股沟淋巴结肿大中的鳞状细胞癌转移、女性腋窝淋巴结肿大中的腺癌转移、女性因腺癌导致的恶性腹水、血清前列腺特异性抗原水平升高的男性的成骨性骨转移、具有生殖腺外生殖细胞瘤特征的低分化肿瘤、低分化神经内分泌癌以及仅有一处转移的患者。对于其他患者必须考虑化疗,尽管最佳方案尚未完全确立。

相似文献

1
[Therapeutic management of cancer of unknown primary site by pathological types].[按病理类型对原发部位不明癌症的治疗管理]
Rev Clin Esp. 2009 Oct;209(9):439-43. doi: 10.1016/s0014-2565(09)72517-2.
2
Diagnostic and therapeutic management of cancer of an unknown primary.原发灶不明癌症的诊断与治疗管理
Eur J Cancer. 2003 Sep;39(14):1990-2005. doi: 10.1016/s0959-8049(03)00547-1.
3
Poorly differentiated neuroendocrine carcinoma of unknown primary site. A newly recognized clinicopathologic entity.原发部位不明的低分化神经内分泌癌。一种新认识的临床病理实体。
Ann Intern Med. 1988 Sep 1;109(5):364-71. doi: 10.7326/0003-4819-109-5-364.
4
Diagnosis and management of metastatic neoplasms with unknown primary.原发灶不明的转移性肿瘤的诊断与管理
Semin Diagn Pathol. 2018 May;35(3):199-206. doi: 10.1053/j.semdp.2017.11.013. Epub 2017 Nov 26.
5
Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary tumor site.原发肿瘤部位不明的低分化癌和低分化腺癌。
Semin Oncol. 1993 Jun;20(3):279-86.
6
[Unknown primary cancer].[原发癌不明]。
Gan To Kagaku Ryoho. 1998 Jan;25(1):1-6.
7
[Standards, Options and Recommendations for the management of patient with carcinoma of unknown primary site].[不明原发部位癌患者管理的标准、选项与建议]
Bull Cancer. 2002 Oct;89(10):869-75.
8
Metastatic adeno or undifferentiated carcinoma from an unknown primary site--natural history and guidelines for identification of treatable subsets.
Q J Med. 1987 Feb;62(238):143-61.
9
[Metastatic carcinoma of unknown origin].[原发灶不明的转移性癌]
Bull Cancer. 1998 Jul;85(7):609-17.
10
Treatment for patients with unknown primary cancer and favorable prognostic factors.对原发性癌症不明但具有有利预后因素的患者的治疗。
Semin Oncol. 2009 Feb;36(1):44-51. doi: 10.1053/j.seminoncol.2008.10.006.